diagnosis of prostate cancer

Active monitoring is an accepted and widely adopted option in the medical community over the past 10 years as a way to reduce unnecessary treatment of prostate cancer.

Lead researcher Dr. Eric Klein said this blood test targets a protein called PSA. PSA will increase if there is a tumor.